Net profit of Aarti Drugs rose 29.33% to Rs 45.28 crore in the quarter ended September 2025 as against Rs 35.01 crore during the previous quarter ended September 2024. Sales rose 9.10% to Rs 652.79 crore in the quarter ended September 2025 as against Rs 598.33 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales652.79598.33 9 OPM %12.9111.21 - PBDT76.6759.60 29 PBT60.4145.88 32 NP45.2835.01 29 Powered by Capital Market - Live News

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 7 November 2025.Powered by Capital Market - Live News

Aarti Drugs announced that the 40th Annual General Meeting(AGM) of the company will be held on 24 September 2025.Powered by Capital Market - Live News

Net profit of Aarti Drugs rose 62.18% to Rs 53.91 crore in the quarter ended June 2025 as against Rs 33.24 crore during the previous quarter ended June 2024. Sales rose 6.33% to Rs 590.51 crore in the quarter ended June 2025 as against Rs 555.34 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales590.51555.34 6 OPM %12.5511.70 - PBDT65.8357.36 15 PBT51.1143.98 16 NP53.9133.24 62 Powered by Capital Market - Live News

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 18 July 2025.Powered by Capital Market - Live News